{"status":"ok","message-type":"event-list","message":{"next-cursor":"f73c377d-3de1-fa28-0c73-b53d47806bde","total-results":10,"items-per-page":1000,"events":[{"license":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/","obj_id":"https:\/\/doi.org\/10.1172\/jci5929","source_token":"45a1ef76-4f43-4cdc-9ba8-5a6ad01cc231","occurred_at":"2017-06-14T15:04:53Z","subj_id":"http:\/\/twitter.com\/mattsiegel\/statuses\/875006133613715456","id":"b4c3bd30-51f8-4aa5-bf82-cb1172523947","evidence_record":"https:\/\/evidence.eventdata.crossref.org\/evidence\/20170617-twitter-b876a500-956a-414d-bf37-17553fe46ef2","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"pid":"http:\/\/twitter.com\/mattsiegel\/statuses\/875006133613715456","title":"Tweet 875006133613715456","issued":"2017-06-14T15:04:53.000Z","author":{"url":"http:\/\/www.twitter.com\/mattsiegel"},"original-tweet-url":"http:\/\/twitter.com\/mattsiegel\/statuses\/875006133613715456","original-tweet-author":null,"alternative-id":"875006133613715456"},"source_id":"twitter","obj":{"pid":"https:\/\/doi.org\/10.1172\/jci5929","url":"http:\/\/www.jci.org\/articles\/view\/5929"},"timestamp":"2017-06-18T21:20:34Z","relation_type_id":"discusses"},{"license":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/","obj_id":"https:\/\/doi.org\/10.1172\/jci5929","source_token":"45a1ef76-4f43-4cdc-9ba8-5a6ad01cc231","occurred_at":"2017-07-12T04:30:17Z","subj_id":"http:\/\/twitter.com\/mattsiegel\/statuses\/884993291917328384","id":"95ee316b-104c-49be-a283-9b71ba77306b","evidence_record":"https:\/\/evidence.eventdata.crossref.org\/evidence\/20170712-twitter-99aec548-5ad1-4ebf-ac05-e5d384950584","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"pid":"http:\/\/twitter.com\/mattsiegel\/statuses\/884993291917328384","title":"Tweet 884993291917328384","issued":"2017-07-12T04:30:17.000Z","author":{"url":"http:\/\/www.twitter.com\/mattsiegel"},"original-tweet-url":"http:\/\/twitter.com\/mattsiegel\/statuses\/884993291917328384","original-tweet-author":null,"alternative-id":"884993291917328384"},"source_id":"twitter","obj":{"pid":"https:\/\/doi.org\/10.1172\/jci5929","url":"http:\/\/www.jci.org\/articles\/view\/5929"},"timestamp":"2017-07-12T04:31:56Z","relation_type_id":"discusses"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1172\/jci5929","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2012-08-23T00:00:00Z","subj_id":"https:\/\/lens.org\/109-597-904-029-146","id":"60ecf0a1-e702-9a4d-ec5b-f4638b41fd70","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Cyclic Peptide Cyclo (L -Arginyl - Glycyl - L -Aspartyl - D - Phenylalanyl - N-Methyl - L -Valyl), Compositions Thereof, And Use Thereof In Methods For Treating Graft -Versus - Host Disease","pid":"https:\/\/lens.org\/109-597-904-029-146","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-10T02:50:22Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1172\/jci5929","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2005-08-02T00:00:00Z","subj_id":"https:\/\/lens.org\/141-506-655-320-277","id":"895d4b3f-aeb3-8be7-6eb5-8b7faebb5164","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Neovascular-Targeted Immunoconjugates","pid":"https:\/\/lens.org\/141-506-655-320-277","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-10T11:04:15Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1172\/jci5929","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2010-12-28T00:00:00Z","subj_id":"https:\/\/lens.org\/016-378-874-643-740","id":"9ca30bdf-c7e4-bc81-c4bd-368dfd222c58","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Neovascular-Targeted Immunoconjugates","pid":"https:\/\/lens.org\/016-378-874-643-740","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-10T16:52:03Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1172\/jci5929","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2011-12-06T00:00:00Z","subj_id":"https:\/\/lens.org\/017-203-659-745-13X","id":"29f1051a-b7b2-a7ae-a07e-db58dbc67a3c","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Neovascular-Targeted Immunoconjugates","pid":"https:\/\/lens.org\/017-203-659-745-13X","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-10T19:13:11Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1172\/jci5929","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2007-02-13T00:00:00Z","subj_id":"https:\/\/lens.org\/178-156-901-790-086","id":"c0d1d1e8-db45-3cf1-4a7f-9f1e43a56f1a","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Methods Of Modulating Fibrosis","pid":"https:\/\/lens.org\/178-156-901-790-086","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-10T20:57:51Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1172\/jci5929","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2010-11-23T00:00:00Z","subj_id":"https:\/\/lens.org\/038-055-310-223-128","id":"af076095-7e72-e8ce-a6f9-0b2da9cbe85b","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Anti-Inflammatory Activity Of Phenethylisothiocyanate (Peitc) And The Barbarea Verna Seed Preparation Containing This Compound","pid":"https:\/\/lens.org\/038-055-310-223-128","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-11T07:49:54Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1172\/jci5929","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2011-02-15T00:00:00Z","subj_id":"https:\/\/lens.org\/077-596-736-963-154","id":"221dd9a8-c691-7dbf-9c5a-e532bfe16979","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Neovascular-Targeted Immunoconjugates","pid":"https:\/\/lens.org\/077-596-736-963-154","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-11T18:15:35Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1172\/jci5929","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2013-03-05T00:00:00Z","subj_id":"https:\/\/lens.org\/099-353-369-346-34X","id":"f73c377d-3de1-fa28-0c73-b53d47806bde","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Neovascular-Targeted Immunoconjugates","pid":"https:\/\/lens.org\/099-353-369-346-34X","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-12T00:26:34Z","relation_type_id":"cites"}]}}